Cubist Systematic Strategies’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $11.7M | Buy |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $4.12M | Buy |
|
|||||
|
2023
Q4 | $2.64M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $17.3M | Buy |
|
|||||
|
2023
Q1 | $2.75M | Sell |
|
|||||
|
2022
Q4 | $11.5M | Buy |
|
|||||
|
2022
Q3 | $7.39M | Buy |
|
|||||
|
2022
Q2 | $1.38M | Sell |
|
|||||
|
2022
Q1 | $12.7M | Buy |
|
|||||
|
2021
Q4 | $8.2M | Buy |
|
|||||
|
2021
Q3 | $5.81M | Sell |
|
|||||
|
2021
Q2 | $9.85M | Buy |
|
|||||
|
2021
Q1 | $5.86M | Buy |
|
|||||
|
2020
Q4 | $2.06M | Buy |
|
|||||
|
2020
Q3 | $809K | Sell |
|
|||||
|
2020
Q2 | $1.8M | Sell |
|
|||||
|
2020
Q1 | $2.55M | Sell |
|
|||||
|
2019
Q4 | $2.71M | Sell |
|
|||||
|
2019
Q3 | $2.66M | Buy |
|
|||||
|
2019
Q2 | $1.92M | Buy |
|
|||||
|
2019
Q1 | $754K | Buy |
|
|||||
|
2018
Q4 | $370K | Sell |
|
|||||
|
2018
Q3 | $1.62M | Buy |
|
|||||
|
2018
Q2 | $876K | Buy |
|
|||||
|
2018
Q1 | $41K | Sell |
|
|||||
|
2017
Q4 | $377K | Sell |
|
|||||
|
2017
Q3 | $402K | Sell |
|
|||||
|
2017
Q2 | $548K | Buy |
|
|||||
|
2017
Q1 | $331K | Buy |
|
|||||
|
2016
Q4 | $61K | Sell |
|
|||||
|
2016
Q3 | $2.49M | Sell |
|
|||||
|
2016
Q2 | $3.32M | Sell |
|
|||||
|
2016
Q1 | $5.84M | Buy |
|
|||||
|
2015
Q4 | $2.99M | Sell |
|
|||||
|
2015
Q3 | $3.29M | Buy |
|
|||||
|
2015
Q2 | $2.72M | Sell |
|
|||||
|
2015
Q1 | $2.88M | Sell |
|
|||||
|
2014
Q4 | $2.37M | Buy |
|
|||||
|
2014
Q3 | $87K | Sell |
|
|||||
|
2014
Q2 | $961K | Buy |
|